Arca
Skip to content
Tools
Tools

Kinetoplast DNA

Nucleic acid in Trypanosoma brucei that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 1
  • In phases 1 to 3: 1
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2

Approved1

  • Pentamidine

Phase 31

  • Pafuramidine

Phase 20

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
      PentamidineApprovedMerck & Co. (MSD)Small moleculeInhibitorKinetoplast DNA inhibitor5
      PafuramidinePhase 3Immtech Pharmaceuticals, IncSmall moleculeInhibitorKinetoplast DNA inhibitor0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 5 in all, from ClinicalTrials.gov.
      A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)PentamidinePhase 2 / Phase 3Not yet recruitingMerck Sharp & Dohme LLCNov 5, 2026
      Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic CancerPentamidinePhase 1RecruitingUniversity of OklahomaSep 18, 2026
      Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)PentamidinePhase 3Not yet recruitingInstitute of Tropical Medicine, BelgiumMar 10, 2026
      Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)PentamidinePhase 4Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health CentreJan 21, 2026
      Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral MiltefosinePentamidinePhase 2RecruitingFundacion Nacional de DermatologiaAug 13, 2024

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2366047, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.